Home
News
Videos
Podcasts
Menu
Акционерное общество "ТВ БРИКС"
tvbrics@tvbrics.com
Рубцов переулок, д.13, Москва, 105082, RU
+74996425304
Currencies:
RUB/USD 0,0119
BRL/USD 0,1942
0,0008
INR/USD 0,0104
CNY/USD 0,149
ZAR/USD 0,0615
0,0002
IDR/USD 0,0001
SPACE FOR MEDIA DIPLOMACY
14:30 «Lеt's be clear»
14:30 «Lеt's be clear»
Now 16+
14:30

«Lеt's be clear»

It is indicated Moscow time in the programme. Please take into account the time difference with your time zone.
15:00 «BRICSreport»
Next
15:00

«BRICSreport»

16+
15:15

«BRICSterview»

16+
15:30

«Laboratorium»

16+
Menu

Vietnam approves sale of Russian anti-cancer drug

The Russian anti-tumour drug has been registered in Vietnam for three years

The Ministry of Health of Vietnam has granted permission for the sale of a Russian-made anti-cancer medicine containing the active ingredient pembrolizumab. This was reported by the Vietnam News Agency, a partner of TV BRICS.

A total of 14 vaccines and biological products have been approved for circulation over the next three years. The active ingredient is used to treat more than 14 types of cancer, including melanoma, lung, cervical, breast, bowel, and kidney cancers.

Vietnamese doctors describe cancer as one of the most serious and widespread health challenges of modern times. In 2022, 180,480 new cases were recorded across the country. The most common forms are breast, liver, lung and colorectal cancers.

Modern methods of cancer treatment in Vietnam include surgery, chemotherapy, radiotherapy, targeted therapy and immunotherapy. In all treatment protocols, next-generation medicines such as pembrolizumab play an important role.

Photo: Choreograph / iStock